Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques in Alzheimer’s Brains
Masahiro Ono,Yan Cheng,Hiroyuki Kimura,Mengchao Cui,Shinya Kagawa,Ryuichi Nishii,Hideo Saji
DOI: https://doi.org/10.1021/jm200057u
IF: 8.039
2011-01-01
Journal of Medicinal Chemistry
Abstract:In vivo imaging of beta-amyloid plaques in the brain may lead to the early diagnosis of Alzheimer's disease (AD) and monitoring of the progression and effectiveness of treatment. In the present study, we report on the development two potential PET probes, [F-18]FPYBF-2 ([F-18]10) and [F-18]FPHBF-2 ([F-18]21), for imaging of beta-amyloid plagues in AD brain. In experiments in vitro, 10 and 21 displayed high affinity for A beta(1-42) aggregates (K-i = 2.41 and 3.85 nM, respectively). In biodistribution experiments using normal mice, they displayed high uptake in the brain (7.38 and 8.18% ID/g at 2 mm postinjection,, respectively), and the radioactivity washed out from the, brain rapidly (3.15 and 3.87% ID/g at 60 min postinjection, respectively), which is highly desirable for beta-amyloid imaging agents. In vivo, they clearly labeled beta-amyloid plaques in Tg2576 mice. Furthermore, the specific labeling of beta-amyloid plaques by 10 and 21 was observed in autoradiographs of sections of autopsied AD brain. These new fluorinated benzofuran derivatives are promising PET probes for imaging cerebral beta-amyloid plaques.